| Malignant (n = 9) | Benign (n = 28) | P value |
---|---|---|---|
Age, years, median (range) | 64 (50-77) | 49 (24-81) | 0.051 |
Gender (n) | Â | Â | 0.036 |
Male | 6 | 6 | Â |
Female | 3 | 22 | Â |
Symptoms | Â | Â | 0.446 |
Yes | 7 | 17 | Â |
No | 2 | 11 | Â |
Tumor location (n) | Â | Â | 0.573 |
Head and/or uncinate process | 4 | 8 | Â |
Neck | 1 | 2 | Â |
Body and/or tail | 4 | 18 | Â |
PCN classification | Â | Â | 0.251 |
IPMN (intraductal papillary mucinous neoplasm) | 6 | 11 | Â |
MCN (mucinous cystic neoplasm) | 3 | 17 | Â |
Elevated serum carbohydrate antigen (CA19-9) or carcinoembryonic antigen (CEA) | Â | Â | 0.014 |
Yes | 7 | 5 | Â |
No | 2 | 15 | Â |
Tumor size (cm) | Â | Â | 0.403 |
>3 cm | 8 | 20 | Â |
≤3 cm | 1 | 8 |  |